logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

China Power (02380) consolidated total electricity sales for the first 9 months were 95,061,400 MWh

date
27/10/2026
Zhitong Finance APP news, China Power (02380) announced that, based on the Company's preliminary statistics, the consolidated total electricity sales volume of the Company and its subsidiaries (collectively, the "Group") for September 2026 was 9.7103 million MWh, an increase of 2.58% compared with the same month last year, while the consolidated total electricity sales volume for the first nine months of 2026 was 95.0614 million MWh.
Latest
1 m ago
CSPC Pharmaceutical Group (01093.HK): The Phase I/II clinical study results of SYS6043 (B7-H3 ADC) for the treatment of advanced breast cancer were presented as a rapid oral presentation at the 2026 ESMO Congress.
1 m ago
Jinyuan Co., Ltd. (000546.SZ) released its performance for the first three quarters, with a net loss attributable to shareholders of RMB 225 million.
5 m ago
Zhejiang University Insigma (600797.SH) released its first three quarters performance, with a net loss attributable to shareholders of RMB 59.39 million.
5 m ago
Norwegian Cruise Line and Carnival Cruise Line shares erase losses, turn positive in premarket.
5 m ago
CSPC Pharmaceutical Group (01093.HK): Results from the Phase I/II Clinical Study of the Anti-PD-1/IL-15 Bifunctional Fusion Protein SYS6090 (JMT108) as Monotherapy for Advanced Solid Tumors Presented as a Rapid Oral Presentation at the 2026 ESMO Congress
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.